In Saccharomyces cerevisiae, the Pho84 phosphate transporter acts as the main provider of phosphate to the cell using a proton symport mechanism, but also mediates rapid activation of the PKA (protein kinase A) pathway. These two features led to recognition of Pho84 as a transceptor. Although the physiological role of Pho84 has been studied in depth, the mechanisms underlying the transport and sensor functions are unclear. To obtain more insight into the structure-function relationships of Pho84, we have rationally designed and analysed site-directed mutants. Using a three-dimensional model of Pho84 created on the basis of the GlpT permease, complemented with multiple sequence alignments, we selected Arg 168 and Lys 492 , and Asp 178 , Asp 358 and Glu 473 as residues potentially involved in phosphate or proton binding respectively, during transport. We found that Asp 358 (helix 7) and Lys
INTRODUCTION
In Saccharomyces cerevisiae, transport of P i across the plasma membrane is mediated by five phosphate transporters, i.e. the high-affinity transporters Pho84 [1] and Pho89 [2] , and three low-affinity transporters, Pho87 [3] , Pho90 and Pho91 [4] . The high-affinity system is regulated by the phosphate-signalling PHO pathway [5] . Under external low phosphate conditions, transcription of the high-affinity transporter genes PHO84 and PHO89, as well as the secreted acid phosphatase gene PHO5 and other PHO-responsive genes, is up-regulated [6, 7] . Under such phosphate-limiting conditions, the Pho84 protein is the main permease responsible for the uptake of phosphate in the cell. As a member of the phosphate:H + symporter (PHS, TC 2.A.1.9.1) family, belonging to the MFS (major facilitator superfamily) [8] , Pho84 couples an inward flow of external P i with the proton-driving force p [9, 10] . Moreover, the proton/P i ratio was estimated to be 2-3 H + :1 P i [11, 12] . The Pho84 permease (587 amino acid residues) is predicted to consist of 12 transmembrane segments, arranged in two bundles of six helices [13] . To date the crystal structures of five MFS transporters have been solved: a glycerol-3-phosphate/phosphate antiporter, GlpT [14] ; a lactose:H + symporter, LacY [15] ; the multidrug resistance protein D, EmrD [16] ; the oxalate transporter, OxlT [17] ; and recently the fucose:H + symporter FucP [18] , which has added significantly to our understanding of the structure and mechanisms of membrane transporters. These high-resolution structures reveal a common overall architecture in spite of their sequence divergence. The deduced overall architecture has strengthened the 'rocker-switch' transport mechanism paradigm for all MFS members [19] . On the basis of these experimentally determined structures, the predicted structure of several other MFS members has been in silico modelled. The theoretical model obtained can be used to rationally design mutant alleles in order to study structure-function relationships [20, 21] . However, the proposed mechanistic transport model lacks detailed information concerning the molecular inner workings of these transporters. Moreover, the diversity in substrate specificity amongst MFS members hampers any generalization concerning the amino acid residues involved in the binding of the substrate during transport. In the case of GlpT, mutational studies, complemented with molecular dynamics analysis [22, 23] , have shown that arginine residues at positions 45 and 269 [14] , together with Lys 80 [19] , contribute to a positive surface electrostatic potential enabling initial substrate binding. A similar architecture of the putative binding site in LacY has been observed, where glutamate residues at positions 126 and 269, together with Arg 144 , are involved in substrate binding [24] . However, these two proteins are only distantly related to Pho84 (22 % sequence identity for GlpT, 25 % for LacY). Thus a molecular understanding of the mechanism of transport by Pho84 is still hampered by the lack of experimentally determined structures of proteins with a similar substrate selectivity.
Pho84 functions not only as a transporter of P i , but also mediates rapid activation of PKA (protein kinase A) pathway targets during growth induction by phosphate in phosphate-deprived fermenting cells [25] . This has led to the recognition that the transporter is involved in sensing external P i levels. Combining the function of a transporter and a receptor, Pho84 is now considered a transceptor [26] . Moreover, these two distinct functions are believed to be related to each other by means of the rocker-switch mechanism. The binding of a nutrient will induce a conformational change, which in some way affects a signal-transducing protein to trigger activation of the PKA pathway [27] . Recently, several nontransported phosphate esters have been shown to be able to interact with the Pho84 permease, triggering PKA activation [28] . This indicates that signalling by Pho84 does not require a complete transport cycle of the substrate.
In addition to signalling the external phosphate condition to PKA, the level of Pho84 in the plasma membrane affects the expression level of PHO-responsive genes. Expression of a functional Pho84 is required for repression of PHO5, and a loss-of-function mutation in PHO84 results in constitutive expression of PHO5 [29, 30] . It has been argued that, instead of Pho84 playing a role in communicating the external phosphate level to the intracellular PHO signalling pathway, an intracellular phosphate sensor would be involved [4, 31] . Moreover, a highthroughput screen of mutants defective in PHO5 regulation indicated that two small-molecule kinases, Adk1 (adenylate kinase 1) and Ado1 (adenosine kinase 1), seem to regulate PHO5 expression upstream of Pho81, which acts as a negative regulator of the Pho80-Pho85 CDK (cyclin-dependent kinase) complex [32] . Whether Pho84 itself also plays a role in transferring a plasma membrane-based phosphate-sensing signal directly to the PHO pathway remains unclear.
In the present study, we have used the Pho84 theoretical 3D (three-dimensional) model (Protein Model DataBase ID PM0076296) [33] , complemented with MSAs (multiple sequence alignments) of the Pho84 transporter with other inorganic phosphate transporter homologues, to identify amino acid residues that might be involved in phosphate and proton binding during their translocation. In addition to identifying residues of the putative binding site, we have also obtained a mutant protein, which severely reduced transport activity, but has retained its affinity towards the substrate, as measured by [ 32 P]P i uptake. Moreover, this specific mutant protein also seems to have retained its PKA signalling capacity, but displays a PHO84 loss-offunction phenotype for repression of PHO5.
EXPERIMENTAL

Materials and strains
[
32 P]P i (carrier-free) was obtained from PerkinElmer. Anti-rabbit IgG and chemiluminescence detection kit were obtained from GE Healthcare. Anti-Myc-HRP (horseradish peroxidase) and rabbit HRP-conjugated anti-mouse antibodies were obtained from Invitrogen. All other materials of reagent grade were obtained from commercial sources. Haploid prototrophic S. cerevisiae CEN.PK 113-7D (MATa MAL2-8c SUC2) was provided by Dr Peter Kötter (Institute for Molecular Biosciences, Goethe University, Frankfurt, Germany).
Selection of residues for mutagenesis
To identify functionally important amino acid residues in the Pho84 sequence, a conservation analysis was performed on the basis of MSAs and calculated using ClustalW. 
Strain construction
The PHO84 WT (Pho84 wild-type) gene was amplified from the genome using sense (5 -GAGAGAGAGACATATGATGAGTTC-CGTCAATAAAGAT-3 ) and antisense (5 -GAGAGAGAGA-GGATCCTGCTTCATGTTGAAGTTGAGA-3 ) primers and cloned into the pU6H2MYC plasmid [34] using NdeI and BamHI endonucleases, yielding the construct pU6H2MYC/PHO84
WT . The mutants were prepared by oligonucleotide-directed sitespecific mutagenesis using the plasmid containing the PHO84 WT gene. The synthetic oligonucleotides used are listed in Table 1 . The mutagenesis was performed using the Stratagene QuikChange TM II mutagenesis kit, according to the manufacturer's protocol. All mutant constructs were confirmed by DNA sequencing of the entire gene. With pU6H2MYC/PHO84
WT and pU6H2MYC/PHO84
MUT (Pho84 mutation) as templates, a PCRamplified cassette containing the sequence encoding the last 1.3 kb of the PHO84 WT and PHO84 MUT , the sequence encoding the c-Myc, hexa-histidine epitope and selection [Kan R (kanamycin resistance)] marker, was subsequently transformed into CEN.PK 113 7D [35] and exchanged by homologous recombination. After selection on YPD [1 % (w/v) yeast extract/2 % (w/v) peptone/2 % (w/v) glucose]/G418 (200 μg/ml) plates, colonies were restreaked on fresh YPD/G418 (200 μg/ml) plates and positive colonies were verified by PCR, sequencing and immunoblot analysis.
Growth conditions
Cells expressing Pho84
WT , Pho84 WT -Myc and Pho84 MUT -Myc were precultivated aerobically for 12 h in YPD medium at 30
• C under continuous agitation (transformed cells were kept in the presence of 200 μg/ml G418), washed twice and inoculated (D 600 = 0.5) in SC (synthetic complete) HP i (high inorganic phosphate; 10 mM KH 2 PO 4 ) or LP i (low inorganic phosphate; 200 μM KH 2 PO 4 ) medium, supplemented with 2 % (w/v) glucose. Cells in LP i conditions were grown aerobically at 30
• C and 200 rev./min for 6 h. Samples for phosphate assays and Western blot analysis were withdrawn at the indicated time points.
Spot tests of yeast growth
After dilution to a D 600 of 0.3, a 10-fold dilution series was spotted on HP i and LP i SC medium containing 200 μg/ml G418. Plates were incubated at 30
• C and growth was recorded after 3 days of culture. MUT -Myc grown in LP i medium was assayed by addition of 2 μl of [ 32 P]P i (carrier-free, 0.18 Ci/μmol; 1 mCi = 37 MBq) and phosphate to a final concentration of 0.22 mM. For the determination of total transport activity, a final phosphate concentration of 0.11 mM was used. Cells were resuspended at 0.1 mg/ml (wet weight) in buffer containing 25 mM Tris-succinate, pH 4.5, and 3 % (w/v) glucose. Aliquots of 30 μl were incubated for 10 min at room temperature (22
• C). After 10 min, 3 ml of ice-cold 25 mM Tris-succinate buffer, pH 4.5, was added to stop the initial reaction. The cells were rapidly filtered (Whatman GF/F) and radioactivity retained on the filters was determined by liquid scintillation spectrometry.
Isolation of plasma membranes and immunoblotting
Yeast membranes were separated on sucrose gradients as described previously [36] , with some minor changes made to the protocol. Briefly, cells were grown for 6 h in 400 ml of LP i medium, harvested and resuspended in sucrose breaking buffer [0.4 M sucrose, 10 mM Tris/HCl, pH 7.6, 1 mM EDTA and protease inhibitor cocktail (Sigma)]. After the cells were disrupted with glass beads (425-600 μm; Sigma), the suspension was cleared from cell debris and unbroken cells by centrifugation (530 g for 20 min at 4
• C). The resulting supernatant was centrifuged at 21 000 g for 40 min at 4
• C, subsequently the crude membranes were placed on top of a discontinuous sucrose gradient (0.4, 1.1, 1.65 and 2.25 M sucrose) containing 10 mM Tris/HCl, pH 7.6, and 1 mM EDTA. After centrifugation at 29 000 rev./min (Beckman SW55 Ti rotor) for 14 h at 4
• C, fractions of band 3 from the top, which contained the enriched plasma membranes, were collected and resuspended in sucrose breaking buffer. After centrifugation for 21 000 g for 60 min at 4
• C, the pellets were dissolved in 20 mM Tris/HCl, pH 7.6, 50 mM NaCl, 10 % (v/v) glycerol, 1 mM EDTA, 0.1 % n-dodecyl β-D-maltoside, 1 mM DTT, 1 mM PMSF and protease inhibitor cocktail, and protein concentration was determined using the BCA (bicinchoninic acid) method (Pierce). Protein samples (3 μg) were mixed with sample buffer prior to separation by SDS/PAGE using a 10 % Laemmli system [37] . Immunoblotting was carried out on PVDF membranes (Immobilon-P; Millipore) according to the Western blotting protocol (GE Healthcare). The primary antibodies used in immunoblotting were monoclonal antibodies against the c-Myc epitope tag (anti-Myc-HRP; 1:4000 dilution), and against Pma1 (plasma membrane marker; Abcam; 1:5000 dilution). The secondary antibody (HRP-conjugated rabbit antimouse) against Pma1 was used at a dilution of 1:5000. After a short incubation with chemiluminescent substrate, the blot was exposed to the X-ray film for 1.5 min. The molecular mass of the separated proteins was determined by the relative mobility of the pre-stained protein markers (Fermentas).
Acid phosphatase assays
For liquid assays, rAPase (repressible acid phosphatase) activity was measured using whole cells as a source of enzyme and p-nitrophenyl phosphate (Sigma) as substrate, essentially as described previously [38] . Yeast strains were grown overnight in 5 ml of YPD at 30
• C, centrifuged (5000 g for 5 min at 4
• C) and washed twice in LP i SC medium (200 μg/ml G418) and then resuspended in 15 ml of LP i and HP i (200 μg/ml G418) SC medium. Cells were grown at 30
• C under continuous agitation for 3 h, after which 80 μl of cell suspension was harvested and washed once with acetate buffer (60 mM sodium acetate, pH 4.5), and resuspended in 80 μl of acetate buffer containing 1 mM p-nitrophenyl phosphate (final concentration). The reaction was incubated at 25
• C for 1 h before being stopped by addition of 20 μl of saturated Na 2 CO 3 . Cells were removed by centrifugation (5000 g for 5 min at 4
• C) before measuring the A 405 . The relative rAPase activity was determined by the formula A 405 /A 600 ×t, where t is the time in minutes of the incubation.
Trehalase activity measurements
Cells were cultured at 30
• C to exponential phase (D 600 = 1.0-1.5) in SD medium [1.7 g/l of YNB (yeast nitrogen base) and 5 g/l of (NH 4 ) 2 SO 4 ] with 2 % (w/v) glucose. Mid-exponential phase cells were harvested and transferred to phosphate starvation medium (5.7 g/l YNB without phosphate with ammonium sulfate) with 4 % (w/v) glucose and appropriate auxotrophic supplements. Cells were starved of phosphate for 3 days at 30
• C under continuous shaking and starvation medium was refreshed daily. The phosphate-starved glucose-repressed cells were rapidly cooled on ice and harvested by centrifugation (5000 g for 5 min at 4
• C). The pellet was washed twice with ice-cold 25 mM Mes buffer, pH 6.0, and resuspended in phosphate starvation medium with 4 % (w/v) glucose and incubated at 30
• C with shaking. After 30 min of incubation, 1 mM KH 2 PO 4 was added to the culture. Samples of 75 mg of cells/ml were taken at the indicated time points. Cells were rapidly cooled by addition of ice-cold water, centrifuged (5000 g for 5 min at 4
• C) and re-suspended in 0.5 ml of ice-cold 25 mM MES buffer, pH 7.0, for extraction. Crude cell extracts were prepared as described previously [38] and dialysed (BRL microdialysis system) against 25 mM Mes buffer, pH 7.0, with 50 μM CaCl 2 at 4
• C. Trehalase activity in dialysed cell extracts was determined using a coupled enzymatic reaction of glucose oxidase and peroxidase with glucose as described previously [39] . The specific activity was expressed as nmol of glucose liberated per min per mg of protein. The total amount of protein in the samples was determined using a standard method described previously [40] .
RESULTS
Rationale of the mutagenesis design
To identify residues contributing to phosphate binding and/or translocation, an MSA of Pho84 with selected phosphate transporters from plants, fungi and bacteria was performed. The highest level of conservation amongst the aligned proteins was found in the transmembrane helices ( Figure 1A) . However, not all transmembrane helices of Pho84 are involved in the lining of the putative translocation channel. For the members belonging to the MFS, helices 1, 2, 4, 5, 7, 8, 10 and 11 are predicted to be channel-lining domains [41] . Since Pho84 is a member of the MFS, we selected only these helices for further analysis. This showed that helices 4, 7, 10 and 11 harboured several highly conserved residues. The amino acid sequence of LacY and GlpT were included in the alignment. GlpT is an organic phosphate/inorganic phosphate antiporter [14] , which served as a template for modelling Pho84, and LacY is a sugar/proton coupled symporter [15] . Highlighted in Figure 1 (H10) and Lys 492 (H11), which are conserved in all phosphate carrier proteins used for the MSA. One of the shared features amongst the MFS members whose crystal structure has been resolved is the location of the putative substrate-binding site. For the GlpT and LacY transporters, the hydrophilic substratebinding sites are formed by H1, H4 and H5 of the N-terminal domain, and H7 and H11 of the C-terminal domain [42] . A direct consequence of using the GlpT structure as a template to model the structure of Pho84 is that the putative substratebinding site might be located at a similar position. The conserved residues were mapped on the Pho84 3D model ( Figures 1B  and 1C guanidium is approximately 4.9 Å. Since the model is that of an inward-facing conformation, the distance measured might be reduced when the outward-facing conformation is obtained, allowing the formation of a salt bridge.
Impact of mutations on the ability of Pho84 to transport phosphate
Candidate amino acid residues involved in phosphate binding and/or translocation were selected on the basis of their conservation and their position in the 3D Pho84 structural model and subsequently subjected to site-directed mutagenesis.
For this purpose, an integration cassette was constructed originating from the pU6H2MYC vector and containing wildtype or mutant PHO84 alleles. These cassettes were introduced into the genome at the pho84Δ locus by means of homologous recombination so that the wild-type or mutant PHO84 alleles were expressed under the control of the PHO84 promoter.
Spot tests to assess growth of the mutant strains were performed to rapidly assess changes in phosphate transport capability (Figure 2 ). When compared with the wild-type Pho84 strain (CEN.PK 113 7D PHO84 Myc ), the strain with Asp 358 in Pho84 replaced by glutamic acid showed drastically reduced growth under LP i conditions. Similarly, replacing Lys 492 with glutamic acid also reduced growth under LP i conditions. Hence these two residues might be of importance for phosphate uptake. All other mutants displayed wild-type growth under LP i conditions. Under HP i growth conditions, all mutant strains displayed wild-type growth.
In order to determine the impact on total transport activity, P i uptake was measured in the Pho84 WT and Pho84 Mut strains using 110 μM KH 2 PO 4 over a period of 10 min at pH 4.5. The values are shown as a percentage of the wild-type levels ( Figure 3A) . Three outcomes can be distinguished: (i) replacement of Glu 473 with glutamine or lysine, and replacement of Lys 492 with alanine or glutamine, does not influence P i uptake activity; (ii) approximately 50 % reduction in P i uptake activity is observed when Arg 168 is replaced with alanine, glutamine or glutamic acid, when Lys 492 is replaced with glutamic acid, and when Asp 178 is replaced with glutamic acid or asparagine. The reduction in activity is more pronounced when the charge of the residue is altered; (iii) replacement of Asp 358 with asparagine or glutamic acid severely reduces or abolishes activity respectively.
As some of the Pho84 mutants exhibited reduced V max values in comparison with the wild-type Pho84, the plasma membrane was isolated, fractionated and analysed by immunoblotting. Three major fractions (i.e. crude membranes, the light-density fraction and interphase) were quantified by immunoblot analysis. The immunoblot analysis showed that Pho84
WT co-fractionated with the marker protein, Pma1 ( Figures 3B and 3C) , and that all mutant proteins are expressed in a similar manner ( Figure 3D ). Any minor variation in the expression signal detected between the different strains does not count as a reduction in transport. These immunoblot variations are due to intrinsic experimental errors that might occur in plasma membrane fractionation. WT -Myc. Three major fractions were isolated from the top: I, top fraction; II, light density fraction; and III, plasma membrane fraction. (D) Expression levels of c-Myc-tagged Pho84 protein in plasma membrane fractions. All mutant and wild-type strains were grown in LP i conditions, lanes: 1, wild-type; 2, R168A; 3, R168Q; 4, R168E; 5, D178N; 6, D178E; 7, D385N; 8, D385E; 9, E473Q; 10, E473K; 11, K492A; 12, K492Q; and 13, K492E.
Kinetic characteristics of mutant Pho84 transporters
To evaluate the contribution that each residue might have to transporter functionality, we determined the apparent kinetic parameters, K m and V max . The results are summarized in Table 2 . The estimated K m and V max for Pho84
WT in the present study are 61.90 + − 14.45 μM and 20.28 + − 1.911 nmol · min − 1 · g of cells − 1 , dry weight, respectively.
Conserved positively charged residues appear to be important for recognition and binding of phosphate
Replacing Lys
492 with an alanine or glutamic acid, removing or switching the charge of the side chain respectively, had a significant effect on the affinity for inorganic phosphate. Both replacements caused a more than 3-fold increase in K m ( Table 2 ). Substitution of Lys 492 for the uncharged residue glutamine also resulted in a higher K m , but to a lesser extent. For K492Q and K492E, the V max displayed only a minor difference compared with the wild-type. Replacing Lys 492 with alanine, on the other hand, caused a 2-fold increase in V max , and this resulted in a higher steady-state intracellular P i concentration (Supplementary Figure S2 at http://www.BiochemJ. org/bj/445/bj4450413add.htm). Replacing Arg 168 with glutamic acid or glutamine increased the affinity 1.4-fold, whereas R168A did not seem to alter the affinity. In R168A and R168E, the V max is reduced 2-fold, whereas for R168E there is only a minor change.
Conserved negatively charged residues are important for the kinetics of transport
Replacing Asp 358 with glutamic acid resulted in a complete loss of transport activity (Table 2) . D358N, which mimics the irreversibly protonated form of aspartic acid, retained its K m , yet the V max was severely reduced. Substitution of Asp 178 with glutamic acid or asparagine resulted in both cases in a decreased K m and V max , with the first substitution having more impact. Replacing Glu 473 with a glutamine had a drastic negative impact on the K m , yet the V max was only slightly elevated. In the case of E473K, in which the charge of the side chain is switched, both kinetic parameters are unchanged compared with the wild-type transporter.
Defects in transport by Pho84 alter the expression of Pho5
To find out whether any defect in phosphate binding/transport caused by one of the mutations in Pho84 would have an influence on transcriptional expression of the PHO regulon, we assayed secreted rAPase activity, which is a marker for the repression activity of the PHO pathway (Figure 4) . The wild-type strain (i.e.
CEN.PK 113 7D PHO84
Myc ) behaves as expected under HP i and LP i conditions, showing increased secreted phosphatase activity under the latter condition. For most of the mutant Pho84 alleles, there seems to be only a minor variation in secreted phosphatase activity compared with the wild-type strain under both HP i and LP i conditions. Only mutations of Asp 358 cause a pronounced increase in secreted phosphatase activity under HP i conditions. This is consistent with the impairment of transport activity in this allele and the well-established observation that complete inactivation of Pho84 causes derepression of secreted phosphatase activity under HP i conditions [29] .
PKA signalling capacity in transport-impaired mutants
Because of the impact observed on the kinetic parameters in the Asp 358 and Asp 178 mutant alleles, we determined whether these alleles are also affected in Pho84 signalling to the PKA pathway. Measurement of the activity of the PKA target trehalase in strains expressing these mutant Pho84 proteins revealed that all of them are still capable of Pho84-mediated PKA activation ( Figure 5 ). Interestingly, in spite of the severely impaired transport activity of the D358N protein, nearly normal signalling to PKA was observed. Even for the D358E allele, for which transport was virtually absent, signalling to PKA was only reduced by approximately 50 % ( Figure 5 ). This is consistent with previous results indicating that non-transported phosphatecontaining compounds can trigger activation of the PKA pathway through Pho84 [28] . Also, the D178E and D178N mutant proteins, which displayed a significant reduction in their V max value, show almost wild-type trehalase activation.
DISCUSSION
Identification of putative residues involved in phosphate and proton binding
The high-affinity inorganic phosphate transporter, Pho84, of S. cerevisiae has been studied extensively as the main provider of inorganic phosphate under conditions of limited supply of inorganic phosphate. In spite of the extensive information available on the regulation of expression of this protein, little is known about the amino acid residues involved in its transport function. Popova et al. [28] identified residues of the side chain that were exposed as the phosphate-binding site using SCAM (substituted cysteine accessibility method). However, such residues are not necessarily themselves involved in binding the substrate.
Pho84 is a proton symporter [10] and thus should have residues involved in binding the negatively charged phosphate ion and the positively charged proton. In order to identify such residues, we first performed a MSA of Pho84 with a series of homologous proteins from other organisms in order to identify conserved residues. We subsequently mapped these residues on a structural model to identify those located in transmembrane helices probably located adjacent to the phosphate translocation pathway. This approach provided us with a limited set of residues that fulfil the criteria of being highly conserved amongst inorganic phosphate transporters, possessing the correct side chain charge for binding of phosphate or a proton, and localized within the transporter so that they are probably accessible for substrate interaction. This approach provided us with five good candidate residues: the positively charged residues Arg . In all alleles with mutant forms of Lys 492 , the affinity towards phosphate is reduced. The need for a positively charged residue is indicated by the K492A mutation, which causes a loss in affinity. When mutated to glutamic acid, the reduced affinity observed might be a consequence of the repulsion between the negative charges of the residue and phosphate. Introducing a glutamine has a milder effect on affinity owing to the conserved polarity of the residue. In all cases, the V max is the same as in the wild-type transporter or even increases. At first sight, this might seem contradictory to the loss in affinity.
Of the two negatively charged residues in the putative binding site, mutational analysis of Asp 358 indicates that this residue is of pivotal importance for transport activity. When replaced by asparagine, the permease loses transport capacity to a great extent, but retains normal affinity towards the substrate. This indicates that this residue is not involved in direct substrate recognition, but rather in the translocation itself. Since translocation is dependent on proton coupling, Asp 358 appears to be a good candidate residue for binding the co-transported proton. Mutagenesis of putative proton binding residues strongly reduces Pho84 transport without preventing signalling to the PKA pathway Previous work has identified non-transported phosphatecontaining compounds that were able to trigger rapid activation of the PKA pathway in a Pho84-dependent manner [28] . This has provided strong evidence that Pho84 acts as a receptor or transceptor for phosphate activation of the PKA pathway and it showed that signalling by the Pho84 transceptor does not require complete transport of the substrate. Similar results were obtained for the Gap1 amino acid transceptor [44] . Moreover, the observation that certain competitive inhibitors of phosphate transport by Pho84 or amino acid transport by Gap1 were able to trigger signalling and others not indicated that the ligand substrate had to induce a specific conformational state in the transceptor, possibly the occluded or a similar intermediate conformation.
These results suggested that mutagenesis of the amino acid residues responsible for the binding of the co-transported proton of these symporters could block the transport without affecting the signalling capacity. Our present results support this idea. Mutagenesis of Asp 358 to asparagine strongly reduced transport capacity, but caused only a slight reduction in the signalling capacity for phosphate activation of the PKA pathway. Even mutagenesis of Asp 358 to glutamic acid, which completely abolished transport activity, caused only a partial reduction in phosphate-induced signalling. These two Pho84 alleles are the first transceptor alleles in which such a clear separation of transport and signalling is obtained. These results strongly suggest that the proton symport mechanism is only required for transport and not for signalling. Hence, binding of phosphate into the phosphate-binding site of Pho84 is apparently enough to induce the specific conformation that triggers signalling. Binding of the proton is not required to obtain a signalling conformation.
Reduction in Pho84 transport activity correlates with reduction in PHO pathway activity PHO80, PHO85 and PHO84 are required for repression of PHO5, and loss-of-function mutations in these genes cause constitutive expression of PHO5 under HP i conditions [4] . The only two Pho84 alleles for which we observe a similar constitutive expression under HP i conditions are the Asp 358 mutant alleles. Immunoblot analysis shows that both proteins are expressed normally in the plasma membrane. Since both mutant alleles show strongly reduced transport, signalling to the PHO pathway seems to correlate with Pho84 transport activity. Also, in several other alleles with partially reduced transport activity, a partial elevation of rAPase activity under HP i conditions can be observed. Hence it can be concluded that signalling to the PKA and PHO pathway by the Pho84 transceptor has different requirements and therefore the mechanisms involved are probably different.
Conclusions
We have succeeded in identifying the Arg 168 and Asp 358 residues in the Pho84 phosphate:H + symporter as probably involved in binding the phosphate molecule and the proton respectively. By mutating the Asp 358 residue, we have obtained the first transceptor alleles with a clear loss of transport activity without loss of signalling capacity. This suggests that mutagenesis of putative proton-binding residues in transceptors may be a valid general strategy for separating transport and signalling. Finally, we have obtained new evidence that Pho84 transport activity correlates with signalling capacity to the PHO pathway, indicating a different mechanism from that involved in activation of the PKA pathway.
On the basis of our data we suggest the following translocation trajectory (summarized in Figure 6 ) and events in which: (i) Arg 168 may be important for the initial interaction with phosphate. This might be in collaboration with a lysine residue at position 106; (ii) Asp 358 and Lys 492 seem to be directly involved in the transport and recognition of phosphate, and we suggest that these residues are part of the putative binding site. 
